Sars Spike S1 Antibody

Human SARS-CoV-2 Spike Protein S1 IgG (S1-IgG) ELISA Kit

SL3219Hu 96 Tests
EUR 468

Human IgG antibody Laboratories manufactures the sars spike s1 antibody reagents distributed by Genprice. The Sars Spike S1 Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Antibody. Other Sars products are available in stock. Specificity: Sars Category: Spike Group: S1 Antibody

Rabbit IgG Anti SARS-CoV-2 Spike (S1) Polyclonal Antibody

0.1
EUR 405.69
Description: Rabbit polyclonal to SARS-CoV-2 spike glycoprotein subunit 1 (S1).

Rabbit IgG Anti SARS-CoV-2 Spike (S1) Polyclonal Antibody

0.5
EUR 1259.17
Description: Rabbit polyclonal to SARS-CoV-2 spike glycoprotein subunit 1 (S1).

SARS-CoV-2 Spike S1 Protein IgG Antibody ELISA Kit

96T
EUR 280

Rabbit IgG Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

0.1
EUR 489.89
Description: This is a recombinant monoclonal antibody. It is a reformatted antibody made using the variable domain sequences of the original Human IgG1 format.

Rabbit IgG Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

0.5
EUR 1865.15
Description: This is a recombinant monoclonal antibody. It is a reformatted antibody made using the variable domain sequences of the original Human IgG1 format.

Rabbit IgG Anti SARS-CoV-2 Spike (S1) RBD Polyclonal Antibody

0.1
EUR 405.69
Description: Rabbit polyclonal to SARS-CoV-2 receptor binding domain (RBD).

Rabbit IgG Anti SARS-CoV-2 Spike (S1) RBD Polyclonal Antibody

0.5
EUR 1259.17
Description: Rabbit polyclonal to SARS-CoV-2 receptor binding domain (RBD).

S1 Antibody information

SARS-CoV-2 (COVID-19) Spike S1 Antibody (biotin)

9083-biotin-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (EB5)

MAB12455-100 0.1
EUR 375.07
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12440. Antibody is specific for SARS-CoV-2 spike subunit 1 protein.

Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (EB5)

MAB12455-500 0.5
EUR 1312.75
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12440. Antibody is specific for SARS-CoV-2 spike subunit 1 protein.

Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (HH10)

MAB12457-100 0.1
EUR 375.07
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12442. Antibody is specific for SARS-CoV-2 spike subunit 1 protein.

Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (HH10)

MAB12457-500 0.5
EUR 1312.75
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12442. Antibody is specific for SARS-CoV-2 spike subunit 1 protein.

Human IgM Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

MAB12423-50 0.05
EUR 1077.3
Description: This is a recombinant monoclonal antibody. It is a reformatted human antibody made using the variable domain sequences of the original Human IgG1 format.

Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

MAB12422-100 0.1
EUR 489.89
Description: This is a recombinant monoclonal antibody.

Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

MAB12422-500 0.5
EUR 1865.15
Description: This is a recombinant monoclonal antibody.

Rabbit IgG Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

MAB12424-100 0.1
EUR 489.89
Description: This is a recombinant monoclonal antibody. It is a reformatted antibody made using the variable domain sequences of the original Human IgG1 format.

Rabbit IgG Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

MAB12424-500 0.5
EUR 1865.15
Description: This is a recombinant monoclonal antibody. It is a reformatted antibody made using the variable domain sequences of the original Human IgG1 format.

Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

MAB12453-100 0.1
EUR 489.89
Description: This is a recombinant monoclonal antibody.

Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

MAB12453-1000 1.0
EUR 3729.02
Description: This is a recombinant monoclonal antibody.

Human IgG1 Anti SARS-CoV-2 Spike (S1) Antibody (CR3022)

MAB12453-500 0.5
EUR 1865.15
Description: This is a recombinant monoclonal antibody.

SARS-CoV Spike Antibody

3219-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3219-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3221-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3221-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.